26 February 2026 in Gastroenterology
Defecation urgency is a common and highly distressing symptom in patients with irritable bowel syndrome (IBS), but its definition remains insufficiently clear. We aimed to compare different measures of urgency, real-life and rectal sensation thresholds, and their clinical and neural correlates. A total of 150 patients with moderate-severe IBS were enrolled in this cross-sectional study conducted at a specialized gastroenterology clinic. Defecation urgency was evaluated using gastrointestinal symptom diaries, questionnaires, and rectal sensation thresholds. Structural magnetic resonance imaging was performed to explore associations between regional gray matter volume (GMV) and urgency-related measures. Statistical analyses were conducted using nonparametric tests and partial correlation analyses, adjusted for relevant covariates. A P value of <.05 was considered statistically significant. Urgency measures derived from diaries and questionnaires were strongly intercorrelated but showed no significant association with barostat-derived urgency thresholds. All urgency measures were significantly associated with abdominal symptoms, yet only urgency sensation thresholds were specifically correlated with gastrointestinal-specific anxiety. Structural magnetic resonance imaging analyses revealed that symptom-based urgency was associated with reduced GMV in the right (P = .001) and left (P = .015) pregenual anterior cingulate cortex and increased GMV in the right amygdala (P < .050). In contrast, lower barostat urgency was associated with larger GMV in the posterior insula (P = .012), right (P = .007) and left (P = .006) amygdala, and right hippocampus (P = .014). Urgency in IBS reflects a multidimensional phenomenon involving sensory and emotional aspects of gastrointestinal burden. Structural brain differences suggest divergent neural substrates underscoring the importance of distinguishing between experimentally induced and real-life urgency.
20 May 2026 in Scientific Reports
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder characterized by abdominal pain, altered bowel habits, and frequent comorbidity with anxiety and depression. The gut microbiota has been implicated in gut-brain axis (GBA) dysfunction, but consistent microbial signatures remain unclear. We performed whole metagenome shotgun sequencing of stool samples from 63 female patients with moderate to severe IBS and 34 female healthy controls and assessed microbial composition and functional pathways. Microbial richness and diversity were slightly reduced in IBS, though with high variability and no robust separation from controls. Differential abundance analyses revealed enrichment of Streptococcus sp. and the sulfate-reducing bacterium Desulfovibrio piger in IBS, alongside reductions in Bifidobacterium and Methanobrevibacter . Functional profiling identified 39 differentially abundant pathways: amino acid biosynthesis (e.g., L-isoleucine, L-threonine) was more prominent in IBS, while carbohydrate degradation pathways (e.g., galactose, stachyose) were enriched in healthy controls. These findings indicate modest but significant IBS-associated shifts in gut microbial composition and function that may contribute to IBS symptoms. However, high intra-group variability underscores the complexity of IBS and highlights the need for larger, multi-omics studies to define robust microbial markers. These results contribute to a growing body of evidence emphasizing the complexity of gut microbiota-host interactions and the need for high-resolution, systems-level approaches in microbiome-associated disorders.